Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism.
暂无分享,去创建一个
A. Garin | I. Bazin | I Botezatu | O Serdyuk | G Potapova | V Shelepov | R Alechina | Y Molyaka | V Ananév | I Bazin | A Garin | M Narimanov | V Knysh | H Melkonyan | S Umansky | A Lichtenstein | S. Umansky | V. Knysh | H. Melkonyan | A. Lichtenstein | Y. Molyaka | I. Botezatu | V. Shelepov | R. Alechina | O. Serdyuk | G. Potapova | M. Narimanov | V. Ananev | Yuriy Molyaka | Vitaliy Anan’ev | Igor Bazin | August Garin | M. Narimanov
[1] B. Shapiro,et al. Free DNA in the serum of cancer patients and the effect of therapy. , 1977, Cancer research.
[2] F. A. Benko,et al. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. , 1997, British Journal of Cancer.
[3] Y. Kodera,et al. Detection of Tumor DNA in Serum of Colorectal Cancer Patients , 2002, Japanese journal of cancer research : Gann.
[4] Y. Lo,et al. Rapid clearance of fetal DNA from maternal plasma. , 1999, American journal of human genetics.
[5] M. Ishizawa,et al. Simple procedure of DNA isolation from human serum. , 1991, Nucleic acids research.
[6] P. Gennes,et al. Passive entry of a DNA molecule into a small pore. , 1999 .
[7] Y. Lo,et al. Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism. , 1999, Clinical chemistry.
[8] M Monden,et al. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] I. Sargent,et al. Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.
[10] H. Kaatsch,et al. Improved DNA typing of human urine by adding EDTA , 1999, International Journal of Legal Medicine.
[11] Y. Lo. Fetal RhD genotyping from maternal plasma. , 1999, Annals of medicine.
[12] J. Herman,et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. , 1999, Cancer research.
[13] T K Lau,et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. , 1998, American journal of human genetics.
[14] J. Pourrat,et al. Plasma DNA as cell death marker in elderly patients. , 1993, Gerontology.
[15] J. Goedert,et al. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. , 2000, Journal of the National Cancer Institute.
[16] David Sidransky,et al. Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.
[17] N M Hjelm,et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. , 1998, The New England journal of medicine.
[18] A. Kurt,et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.
[19] F. Bischoff,et al. Noninvasive Determination of Fetal RhD Status Using Fetal DNA in Maternal Serum and PCR , 1999, The Journal of the Society for Gynecologic Investigation: JSGI.
[20] D. Labuda,et al. Linkage mapping by simultaneous screening of multiple polymorphic loci using Alu oligonucleotide-directed PCR. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Yamada,et al. A human Y-chromosome specific repeated DNA family (DYZ1) consists of a tandem array of pentanucleotides. , 1986, Nucleic acids research.
[22] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[23] K. Paigen,et al. A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.
[24] D. Seligson,et al. Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.
[25] S. Leung,et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. , 1999, Cancer research.
[26] D. Swinkels,et al. Detection of tumour DNA in serum of colorectal cancer patients. , 1997, Scandinavian journal of clinical and laboratory investigation.
[27] J. Pourrat,et al. Extracellular DNA in blood and urine as a potential marker for cytotoxicity and nephrotoxicity in the mouse. , 1990, Renal failure.